We are excited to announce that VENDYS will be presenting at the 2025 Integrative Healthcare Symposium (IHS) in New York City, New York. Join us from February 20-22 at the Hilton Midtown, booth #1025.
About VENDYS-II
The VENDYS-II device is a state-of-the-art, FDA-cleared, fully automated office-based tool designed to measure vascular reactivity and endothelial function. Endothelial function is a critical indicator of cardiovascular health, as it reflects the ability of blood vessels to dilate and constrict properly. VENDYS-II provides a non-invasive, direct assessment of vascular function, which is essential for early detection and prevention of cardiovascular diseases.
How VENDYS-II Works
The VENDYS-II test begins with an automated blood pressure measurement, followed by cuff occlusion of the right arm for 2 to 5 minutes. During this time, the fingertip temperature in the right hand falls due to the absence of warm circulating blood. Once the cuff is released, blood flow rushes back into the forearm and hand, causing a temperature rebound in the fingertip. This rebound is directly proportional to vascular reactivity and endothelial function
Key Features and Benefits
FDA-Cleared: VENDYS-II is the only FDA-cleared device for measuring vascular reactivity and endothelial function in an office setting.
Non-Invasive: The test is simple, non-invasive, and takes just 15 minutes to complete.
Portable and User-Friendly: VENDYS-II is an all-in-one portable touchscreen device with an interactive audio-guided interface powered by smart algorithms, making it easy to use for both healthcare providers and patients.
Comprehensive Reports: The device provides colorful, easy-to-understand reports that show the patient's Vascular Reactivity Index (VRI) and track changes over time. These reports can help promote patient adherence to lifestyle and medication recommendations.
Clinical and Research Applications: VENDYS-II is optimized for both patient care and clinical research studies, making it a versatile tool for healthcare professionals.
Medicare/Insurance Reimbursed
By providing real-time data on endothelial function, VENDYS-II helps healthcare professionals detect early signs of cardiovascular disease and implement preventive measures. This innovative device is a valuable addition to any practice focused on improving cardiovascular health.
Why Attend IHS 2025?
The Integrative Healthcare Symposium is a premier event for healthcare professionals, offering a platform to explore the latest advancements in integrative medicine. Attendees will have the opportunity to connect with industry leaders, attend educational sessions, and discover innovative products like VENDYS-II.
Register Today and Visit Us at Booth # 1025
We invite you to visit our booth #1025 to see the VENDYS-II device in action. Our team will be present to provide demonstrations and answer any questions you may have. Don't miss this chance to learn how VENDYS-II can enhance your practice and improve patient outcomes. Register for the 2025 Integrative Healthcare Symposium today!
Comments